BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18549440)

  • 1. Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains.
    Brando RJ; Miliwebsky E; Bentancor L; Deza N; Baschkier A; Ramos MV; Fernández GC; Meiss R; Rivas M; Palermo MS
    Clin Exp Immunol; 2008 Aug; 153(2):297-306. PubMed ID: 18549440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection.
    Cabrera G; Fernández-Brando RJ; Mejías MP; Ramos MV; Abrey-Recalde MJ; Vanzulli S; Vermeulen M; Palermo MS
    Int J Med Microbiol; 2015 Dec; 305(8):910-7. PubMed ID: 26456732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.
    Bielaszewska M; Mellmann A; Zhang W; Köck R; Fruth A; Bauwens A; Peters G; Karch H
    Lancet Infect Dis; 2011 Sep; 11(9):671-6. PubMed ID: 21703928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome.
    Schmidt H; Karch H
    J Clin Microbiol; 1996 Oct; 34(10):2364-7. PubMed ID: 8880480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, quantification and isolation of pathogenic shiga toxin Escherichia coli O157:H7 along the production and supply chain of pork around Hubei Province of China.
    Khan SB; Zou G; Xiao R; Cheng Y; Rehman ZU; Ali S; Memon AM; Fahad S; Ahmad I; Zhou R
    Microb Pathog; 2018 Feb; 115():93-99. PubMed ID: 29273508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
    Li B; Liu H; Wang W
    BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.
    Moxley RA; Francis DH; Tamura M; Marx DB; Santiago-Mateo K; Zhao M
    Toxins (Basel); 2017 Jan; 9(2):. PubMed ID: 28134751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
    Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
    Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
    Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin-producing Escherichia coli (STEC) O22:H8 isolated from cattle reduces E. coli O157:H7 adherence in vitro and in vivo.
    Martorelli L; Albanese A; Vilte D; Cantet R; Bentancor A; Zolezzi G; Chinen I; Ibarra C; Rivas M; Mercado EC; Cataldi A
    Vet Microbiol; 2017 Sep; 208():8-17. PubMed ID: 28888654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.
    Leotta GA; Miliwebsky ES; Chinen I; Espinosa EM; Azzopardi K; Tennant SM; Robins-Browne RM; Rivas M
    BMC Microbiol; 2008 Mar; 8():46. PubMed ID: 18366637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemic of EHEC (Escherichia coli O104:H4) in Europe in 2011--clinical and therapeutic problems].
    Simon K; Janocha J
    Przegl Epidemiol; 2012; 66(1):73-7. PubMed ID: 22708302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.